INTEGRA LIFESCIENCES HOLDINGS CORP Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Integra Lifesciences Holdings Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2010 to Q2 2024.
  • Integra Lifesciences Holdings Corp Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$12.4M, a 396% decline year-over-year.
  • Integra Lifesciences Holdings Corp Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $23.6M, a 82% decline year-over-year.
  • Integra Lifesciences Holdings Corp annual Net Income (Loss) Attributable to Parent for 2023 was $67.7M, a 62.5% decline from 2022.
  • Integra Lifesciences Holdings Corp annual Net Income (Loss) Attributable to Parent for 2022 was $181M, a 6.79% increase from 2021.
  • Integra Lifesciences Holdings Corp annual Net Income (Loss) Attributable to Parent for 2021 was $169M, a 26.3% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $23.6M -$12.4M -$16.6M -396% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-29
Q1 2024 $40.2M -$3.28M -$27.5M -114% Jan 1, 2024 Mar 31, 2024 10-Q 2024-07-29
Q4 2023 $67.7M $19.8M -$33.1M -62.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $101M $19.5M -$30.4M -60.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-25
Q2 2023 $131M $4.18M -$40.6M -90.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-29
Q1 2023 $172M $24.2M -$8.68M -26.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-07-29
Q4 2022 $181M $52.9M +$7.56M +16.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $173M $49.9M +$6.69M +15.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-25
Q2 2022 $166M $44.8M +$9.72M +27.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-10-25
Q1 2022 $157M $32.9M -$12.5M -27.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-10-25
Q4 2021 $169M $45.4M -$47.4M -51.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $216M $43.2M +$10.9M +33.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-26
Q2 2021 $206M $35.1M +$35.4M Apr 1, 2021 Jun 30, 2021 10-Q 2022-10-26
Q1 2021 $170M $45.4M +$36.2M +394% Jan 1, 2021 Mar 31, 2021 10-Q 2022-10-26
Q4 2020 $134M $92.7M +$77.4M +505% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-23
Q3 2020 $56.5M $32.3M +$59.9M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$3.48M -$369K -$30.1M -101% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-02
Q1 2020 $26.6M $9.18M -$23.6M -72% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-02
Q4 2019 $50.2M $15.3M -$9.82M -39.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-23
Q3 2019 $60M -$27.6M -$40.9M -308% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-23
Q2 2019 $101M $29.7M +$18.4M +161% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-23
Q1 2019 $82.6M $32.8M +$21.8M +198% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-23
Q4 2018 $60.8M $25.1M -$19.2M -43.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-21
Q3 2018 $80M $13.3M +$10.1M +321% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-21
Q2 2018 $69.9M $11.4M +$541K +4.99% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-21
Q1 2018 $69.3M $11M +$4.6M +71.9% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-21
Q4 2017 $64.7M $44.4M +$16.1M +57% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-26
Q3 2017 $48.6M $3.16M -$17M -84.3% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-26
Q2 2017 $65.6M $10.8M -$1.92M -15.1% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-26
Q1 2017 $67.5M $6.39M -$7.03M -52.4% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-26
Q4 2016 $74.6M $28.2M +$13.3M +88.6% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 $61.3M $20.1M +$52M Jul 1, 2016 Sep 30, 2016 10-K 2018-03-01
Q2 2016 $9.27M $12.8M +$7.76M +155% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-01
Q1 2016 $1.52M $13.4M +$5.04M +60.1% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-01
Q4 2015 -$3.52M $15M -$2.19M -12.7% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-23
Q3 2015 -$1.33M -$31.9M -$41.7M -425% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-23
Q2 2015 $40.4M $5M +$173K +3.59% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-23
Q1 2015 $40.2M $8.38M +$6.18M +280% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-23
Q4 2014 $34M $17.2M +$3.4M +24.7% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-26
Q3 2014 $30.6M $9.81M +$40.1M Jul 1, 2014 Sep 30, 2014 10-K 2016-02-26
Q2 2014 -$9.53M $4.83M +$3.31M +217% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-26
Q1 2014 -$12.8M $2.21M +$8.23M Jan 1, 2014 Mar 31, 2014 10-K 2016-02-26
Q4 2013 -$21.1M $13.8M +$985K +7.7% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-27
Q3 2013 -$22.1M -$30.3M -$43.5M -330% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-27
Q2 2013 $21.5M $1.52M -$6.99M -82.1% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-27
Q1 2013 $28.5M -$6.03M -$12.7M -190% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-27
Q4 2012 $41.2M $12.8M +$8.23M +180% Oct 1, 2012 Dec 31, 2012 8-K 2014-06-20
Q3 2012 $33M $13.2M +$1.97M +17.5% Jul 1, 2012 Sep 30, 2012 8-K 2014-06-20
Q2 2012 $31M $8.51M +$7.82M +1118% Apr 1, 2012 Jun 30, 2012 8-K 2014-06-20
Q1 2012 $23.2M $6.69M -$4.79M -41.7% Jan 1, 2012 Mar 31, 2012 8-K 2014-06-20
Q4 2011 $28M $4.56M -$14.2M -75.8% Oct 1, 2011 Dec 31, 2011 10-K 2013-02-26
Q3 2011 $42.2M $11.2M -$5.24M -31.8% Jul 1, 2011 Sep 30, 2011 10-K 2013-02-26
Q2 2011 $47.5M $699K -$14.5M -95.4% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-26
Q1 2011 $61.9M $11.5M -$3.74M -24.5% Jan 1, 2011 Mar 31, 2011 10-K 2013-02-26
Q4 2010 $65.7M $18.8M Oct 1, 2010 Dec 31, 2010 10-K 2012-02-27
Q3 2010 $16.5M Jul 1, 2010 Sep 30, 2010 10-K 2012-02-27
Q2 2010 $15.2M Apr 1, 2010 Jun 30, 2010 10-K 2012-02-27
Q1 2010 $15.2M Jan 1, 2010 Mar 31, 2010 10-K 2012-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.